logo

Achieve Life Sciences Inc. (ACHV)



Trade ACHV now with
  Date
  Headline
10/7/2020 6:33:56 AM Achieve Life Sciences Begins Start Of Phase 3 ORCA-2 Clinical Trial Evaluating Cytisinicline For Smoking Cessation
9/30/2020 8:08:00 AM Achieve Life Sciences Promotes John Bencich To CEO
9/30/2020 8:03:21 AM Achieve Life Sciences Says Promotes John Bencich To CEO
9/18/2020 9:31:58 AM Achieve Life Sciences: RAUORA Trial Data Shows Significantly Fewer Side Effects With Higher Quit Rates For Cytisinicline
9/18/2020 7:09:44 AM Achieve Life Sciences Announces Results From Evaluation Of Cytisinicline Vs Chantix In 5-HT3 Receptor Study
8/4/2020 9:05:48 AM Achieve Life Sciences Prices Public Offering Of 476,187 Shares At $10.50/shr
8/4/2020 9:05:47 AM Achieve Life Sciences Prices Public Offering Of 476,187 Shares At $10.50 Per Share
6/29/2020 8:43:49 AM Achieve Life Sciences Says Cytisinicline Demonstrated Quit Rates At Least As Effective As Varenicline
6/29/2020 8:36:49 AM Achieve Life Sciences Prices $6 Mln Registered Direct Offering